Melanoma Epidemiology and Public Health

Dermatologic Clinics

Volumn 27, Issue 2, 2009, Pages 205-214

  Berwick, Marianne ^a,b   Erdei, Esther ^a   Hay, Jennifer ^c  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Incidence; Melanoma; Mortality

Indexed keywords

DNA; SUNSCREEN; VITAMIN D;

CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CLOTHING; CONFIDENCE INTERVAL; DEVELOPED COUNTRY; DISEASE ASSOCIATION; DISEASE COURSE; DNA REPAIR; FAMILY HISTORY; GENE INTERACTION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEALTH PROGRAM; HUMAN; INCIDENCE; MEDICAL RESEARCH; MELANOCYTIC NEVUS; MELANOMA; MORTALITY; PIGMENTATION; POPULATION; POPULATION RISK; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH SERVICE; REVIEW; SKIN EXAMINATION; SUN EXPOSURE; ULTRAVIOLET RADIATION;

HUMANS; INCIDENCE; MELANOMA; PUBLIC HEALTH; RISK FACTORS; SKIN NEOPLASMS;

EID: 60949103692     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2008.12.002     Document Type: Review

References (86)

1. Mouw T., Koster A., Wright M.E., et al. Education and risk of cancer in a large cohort of men and women in the United States. PLoS ONE 3 (2008) e3639
2. Shack L., Jordan C., Thomson C.S., et al. Variation in incidence of breast, lung and cervical cancer and malignant melanoma of the skin by socioeconomic group in England. BMC Cancer 8 (2008) 271
3. Birch-Johansen F., Huilsom G., Kjaer T., et al. Social inequality and incidence of and survival from malignant melanoma in a population-based study in Denmark, 1994-2003. Eur J Cancer 44 (2008) 2043-2049
4. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
5. American Cancer Society. Cancer facts & figures 2008 (2008), American Cancer Society, Atlanta (GA)
6. Baade P., and Coory M. Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control. Aust N Z J Public Health 29 4 (2005) 383-386
7. Qin J., Berwick M., Ashbolt R., et al. Quantifying the change of melanoma incidence by Breslow thickness. Biometrics 58 3 (2002) 665-670
8. Welch H.G., Woloshin S., and Schwartz L.M. Skin biopsy rates and incidence of melanoma: population based ecological study. BMJ 331 (2005) 481
9. Gandini S., Sera F., Cattaruzza M.S., et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 41 1 (2005) 45-60
10. Elwood J.M., and Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer 73 (1997) 198-203
11. Nelemans P.J., Rampen F.H., Ruiter D.J., et al. An addition to the controversy on sunlight exposure and melanoma risk: a meta-analytical approach. J Clin Epidemiol 48 11 (1995) 1331-1342
12. Armstrong B.K. Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun?. J Dermatol Surg Oncol 14 8 (1988) 835-849
13. Berwick M., and Chen Y.T. Reliability of reported sunburn history in a case-control study of cutaneous malignant melanoma. Am J Epidemiol 141 11 (1995) 1033-1037
14. Whiteman D., and Green A. Melanoma and sunburn. Cancer Causes Control 5 6 (1994) 564-572
15. MacKie R.M., and Aitchison T. Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in Scotland. Br J Cancer 46 6 (1982) 955-960
16. Grob J.J., Gouvernet J., Aymar D., et al. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 66 2 (1990) 387-395
17. Thomas N.E., Edmiston S.N., and Alexander A. Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiol Biomarkers Prev 16 5 (2007) 991-997
18. Whiteman D.C., Watt P., Purdie D.M., et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 95 11 (2003) 806-812
19. Berwick M. Are tanning beds "safe"? Human studies of melanoma. Pigment Cell Melanoma Res 21 5 (2008) 517-519
20. The International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer. Int J Cancer 120 (2006) 1116-1122
21. Veierød M., Weiderpass E., Tho¨m M., et al. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst 95 20 (2003) 1530-1538
22. Massi D., Carli P., Franchi A., et al. Naevus-associated melanomas: cause or chance?. Melanoma Res 9 1 (1999) 85-91
23. Skender-Kalnenas T.M., English D.R., and Heenan P.J. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?. J Am Acad Dermatol 33 6 (1995) 1000-1007
24. Olsen C.M., Zens M.S., Stukel T.A., et al. Nevus density and melanoma risk in women: A pooled analysis to test the divergent pathway hypothesis. Int J Cancer 124 4 (2008) 937-944
25. Chang Y.M., Newton-Bishop J.A., Bishop D.T., et al. A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. Int J Cancer 124 2 (2008) 420-428
26. Gandini S., Sera F., Cattaruzza M.S., et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 41 1 (2005) 28-44
27. Greene M.H., and Fraumeni J.J. The hereditary variant of malignant melanoma. In: Clark W.H., Goldman L.I., and Mastrangelo M.J. (Eds). Human malignant melanoma (1979), Grune & Stratton, New York p. 139-66
28. Kopf A.W., Hellman L.J., Rogers G.S., et al. Familial malignant melanoma. J Am Med Assoc 256 (1986) 1915-1919
29. Ford D., Bliss J.M., Swerdlow A.J., et al. Risk of cutaneous melanoma associated with a family history of the disease. Int J Cancer 62 (1995) 377-381
30. Fitzpatrick T.B. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124 (1988) 869-871
31. Rampen F.H., Fleuren B.A., de Boo T.M., et al. Unreliability of self-reported burning tendency and tanning ability. Arch Dermatol 124 6 (1988) 885-888
32. Raimondi S., Sera F., Gandini S., et al. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer 122 12 (2008) 2753-2760
33. Gudbjartsson D.F., Sulem P., Stacey S.N., et al. MC1R. Nat Genet 40 7 (2008) 886-891
34. Brown K.M., Macgregor S., Montgomery G.W., et al. Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet 40 7 (2008) 838-840
35. Kertat K., Rosdahl I., Sun X.F., et al. The Gln/Gln genotype of XPD codon 751 as a genetic marker for melanoma risk and Lys/Gln as an important predictor for melanoma progression: a case control study in the Swedish population. Oncol Rep 20 1 (2008) 179-183
36. Millikan R.C., Hummer A., Begg C., et al. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. Carcinogenesis 27 3 (2006) 610-618
37. Kadekaro A.L., Wakamatsu K., Ito S., et al. Cutaneous photoprotection and melanoma susceptibility: reaching beyond melanin content to the frontiers of DNA repair. Front Biosci 11 (2006) 2157-2173
38. Han J., Colditz G.A., and Hunter D.J. Lack of associations of selected variants in genes involved in cell cycle and apoptosis with skin cancer risk. Cancer Epidemiol Biomarkers Prev 15 3 (2006) 592-593
39. Berwick M., Orlow I., Hummer A.J., et al. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiol Biomarkers Prev 15 8 (2006) 1520-1525
40. Kefford R., Bishop J.N., Tucker M., et al. Genetic testing for melanoma. Lancet Oncol 3 11 (2002) 653-654
41. Armstrong B.K., Kricker A., and English D.R. Sun exposure and skin cancer. Australas J Dermatol 38 Suppl 1 (1997) S1-S6
42. American Cancer Society. Available at: www.cancer.org. Accessed 2009.
43. Hall H.I., May D.S., Lew R.A., et al. Sun protection behaviors of the U.S. white population. Prev Med 26 4 (1997) 401-407
44. Koh H.K., Bak S.M., Geller A.C., et al. Sunbathing habits and sunscreen use among white adults: results of a national survey. Am J Public Health 87 7 (1997) 1214-1217
45. Coups E.J., Manne S.L., and Heckman C.J. Multiple skin cancer risk behaviors in the U.S. population. Am J Prev Med 34 2 (2008) 87-93
46. Dobbinson S.J., Wakefield M.A., Jamsen K.M., et al. Weekend sun protection and sunburn in Australia trends (1987-2002) and association with SunSmart television advertising. Am J Prev Med 34 2 (2008) 94-101
47. Montague M., Borland R., and Sinclair C. Slip! Slop! Slap! and SunSmart, 1980-2000: Skin cancer control and 20 years of population-based campaigning. Health Educ Behav 28 3 (2001) 290-305
48. Stanton W.R., Moffatt J., and Clavarino A. Community perceptions of adequate levels and reasons for skin protection. Behav Med 31 1 (2005) 5-15
49. Saraiya M., Glanz K., and Briss P. Preventing skin cancer: findings of the Task Force on Community Preventive Services on reducing exposure to ultraviolet light. MMWR Recomm Rep 52 (2003) 1-12
50. Rutten L, Hesse BW, Moser RP, et al. Public understanding of cancer prevention, screening, and survival: Comparison with state-of-science evidence for colon, skin, and lung cancer. J Cancer Educ, in press.
51. Geller A.C., Emmons K.M., Brooks D.R., et al. A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer 107 4 (2006) 806-814
52. Mayer J.A., Lewis E.C., Eckhardt L., et al. Promoting sun safety among zoo visitors. Prev Med 33 3 (2001) 162-169
53. Weinstock M.A., Rossi J.S., Redding C.A., et al. Randomized controlled community trial of the efficacy of a multicomponent stage-matched intervention to increase sun protection among beachgoers. Prev Med 35 6 (2002) 84-92
54. Buller DB, Andersen PA, Walkosz BJ, et al. Randomized trial testing a worksite sun protection program in an outdoor recreation industry. Health Educ Behav 2005;32:514-35.
55. Glanz K., Geller A.C., Shigaki D., et al. A randomized trial of skin cancer prevention in aquatics settings: the Pool Cool program. Health Psychol 21 6 (2002) 579-587
56. Gorham E.D., Mohr S.B., Garland C.F., et al. Do sunscreens increase risk of melanoma in populations residing at higher latitudes?. Ann Epidemiol 17 12 (2007) 956-963
57. Vainio H., Miller A.B., and Bianchini F. An international evaluation of the cancer-preventive potential of sunscreens. Int J Cancer 88 5 (2000) 838-842
58. Autier P., Boniol M., and Dore J.F. Sunscreen use and increased duration of intentional sun exposure: still a burning issue. Int J Cancer 121 1 (2007) 2755-2759
59. Diffey B.L. Sunscreens and melanoma: the future looks bright. Br J Dermatol 153 2 (2005) 378-381
60. Gallagher R.P., Rivers K.J., and Lee T.K. Broad-spectrum sunscreen use and the development of new nevi in white children: a randomized controlled trial. JAMA 283 22 (2000) 2955-2960
61. Whiteman D.C., Brown R.M., Purdie D.M., et al. Melanocytic nevi in very young children: the role of phenotype, sun exposure, and sun protection. J Am Acad Dermatol 52 1 (2005) 40-47
62. van der Pols J.C., Xu C., Boyle G.M., et al. Expression of p53 tumor suppressor protein in sun-exposed skin and associations with sunscreen use and time spent outdoors: a community-based study. Am J Epidemiol 163 11 (2006) 982-988
63. Bauer J., Bu¨ttner P., Wiecker T.S., et al. Effect of sunscreen and clothing on the number of melanocytic nevi in 1,812 German children attending day care. Am J Epidemiol 161 7 (2005) 620-627
64. English D.R., Milne E., and Simpson J.A. Sun protection and the development of melanocytic nevi in children. Cancer Epidemiol Biomarkers Prev 14 12 (2005) 2873-2876
65. English D.R., Milne E., and Simpson J.A. Ultraviolet radiation at places of residence and the development of melanocytic nevi in children (Australia). Cancer Causes Control 17 1 (2006) 103-107
66. Autier P., Dore´ J.F., Cattaruzza M.S., et al. Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children. European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. J Natl Cancer Inst 90 24 (1998) 1873-1880
67. Gallagher R.P., Elwood J.M., and Yang C.P. Is chronic sunlight exposure important in accounting for increases in melanoma incidence?. Int J Cancer 44 5 (1989) 813-815
68. Diffey B. Do white British children and adolescents get enough sunlight?. BMJ 331 (2005) 3-4
69. Hiom S. Public awareness regarding UV risks and vitamin D-the challenges for UK skin cancer prevention campaigns. Prog Biophys Mol Biol 92 1 (2006) 161-166
70. Working Group of the Australian and New Zealand Bone and Mineral Society, and Endocrine Society of Australia and Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 182 6 (2005) 281-285
71. Breitbart E.W., Greinert R., and Volkmer B. Effectiveness of information campaigns. Prog Biophys Mol Biol 92 1 (2006) 167-172
72. Brooks K.R., Brooks D.R., Hufford D., et al. Are television stations and weather pages still reporting the UV index? A national media follow-up study. Arch Dermatol 141 4 (2005) 526
73. Dixon H., and Armstrong B. The UV index. Report of a national workshop on its role in sun protection (1999), NSW Cancer Council and Anti-Cancer Council of Victoria, Sydney
74. Arthey S., and Clarke V.A. Suntanning and sun protection: a review of the psychological literature. Soc Sci Med 40 2 (1995) 265-274
75. Berwick M., Fine J.A., and Bolognia J.L. Sun exposure and sunscreen use following a community skin cancer screening. Prev Med 21 3 (1992) 302-310
76. Grob J.J., Guglielmina C., Gouvernet J., et al. Study of sunbathing habits in children and adolescents: application to the prevention of melanoma. Dermatology 186 2 (1993) 94-98
77. Jackson K.M., and Aiken L.S. A psychosocial model of sun protection and sunbathing in young women: the impact of health beliefs, attitudes, norms, and self-efficacy for sun protection. Health Psychol 19 5 (2000) 469-478
78. Hoerster K.D., Mayer J.A., Woodruff S.I., et al. The influence of parents and peers on adolescent indoor tanning behavior: findings from a multi-city sample. J Am Acad Dermatol 57 6 (2007) 990-997
79. Young A.R., Potten C.S., Chadwick C.A., et al. Photoprotection and 5-MOP photochemoprotection from UVR-induced DNA damage in humans: the role of skin type. J Invest Dermatol 97 5 (1991) 942-948
80. Hay J.L., Meischke H.W., Bowen D.J., et al. Anticipating dissemination of cancer genomics in public health: a theoretical approach to psychosocial and behavioral challenges. Ann Behav Med 34 3 (2007) 275-286
81. Wartman D., and Weinstock M. Are we overemphasizing sun avoidance in protection from melanoma?. Cancer Epidemiol Biomarkers Prev 17 3 (2008) 469-470
82. Epstein D.S., Lange J.R., Gruber S.B., et al. Is physician detection associated with thinner melanomas?. JAMA 281 7 (1999) 640-643
83. US Preventive Services Task Force. Recommendations and rationale for screening for skin cancer. Am J Prev Med 203 Suppl (2001) 44-46
84. Geller A.C., Sober A.J., Zhang Z., et al. Strategies for improving melanoma education and screening for men age > or = 50 years: findings from the American Academy of Dermatological National Skin Cancer Screening Program. Cancer 95 7 (2002) 1554-1561
85. Pennie M.L., Soon S.L., Risser J.B., et al. Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist. Arch Dermatol 143 4 (2007) 488-494
86. Weinstock M.A., Risica P.M., Martin R.A., et al. Melanoma early detection with thorough skin self-examination: the "Check It Out" randomized trial. Am J Prev Med 32 6 (2007) 517-524